Through the electronic distribution list of the SEMI’s GEAS group, all members with clinical experience on the use of biological agents in patients with SAD were invited to participate. Each participating Department, Unit or Section assigned a coordinator and his/her collaborators.
An Expert Committee integrated by the coordinators of each of the participating centers of the BIOGEAS National Registry was established for the discussion of the document of consensus.
After a literature search is made, a draft document will be written and sent via email to all members of the Experts Committee for its discussion and approval.